Literature DB >> 27134891

Fatal Nevirapine-Induced Toxic Epidermal Necrolysis in a HIV Infected Patient.

Sabyasachi Paik1, Sukanta Sen2, Nikhil Era1, Bibhuti Saha3, Santanu Kumar Tripathi4.   

Abstract

Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are the most Severe Cutaneous Adverse Reactions (SCARs) which mainly caused by exposure to drugs and having significant morbidity and mortality. TEN represents an immunologic reaction to a foreign antigen and is most often caused by drugs. Nevirapine (NVP), a non-nucleoside reverse transcriptase inhibitor (NNRTI) is an important component of Highly Active Antiretroviral Therapy (HAART). It is sometimes associated with life-threatening adverse reactions. Here, we report the fatal case of 72-year-old male who developed TEN secondary to intake of nevirapine. This fatal case report will increase awareness among treating physicians for careful monitoring of patients on NNRTI-based antiretroviral therapy and better counseling of the patient on NVP regimen for early identification and reporting of SCARs so that fatalities due to adverse drug reactions can be prevented with timely intervention.

Entities:  

Keywords:  Severe adverse cutaneous drug reactions; Stevens–Johnson syndrome

Year:  2016        PMID: 27134891      PMCID: PMC4843277          DOI: 10.7860/JCDR/2016/16360.7415

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  13 in total

1.  SCORTEN: a severity-of-illness score for toxic epidermal necrolysis.

Authors:  S Bastuji-Garin; N Fouchard; M Bertocchi; J C Roujeau; J Revuz; P Wolkenstein
Journal:  J Invest Dermatol       Date:  2000-08       Impact factor: 8.551

2.  Nevirapine-induced toxic epidermal necrolysis and toxic hepatitis treated successfully with a combination of intravenous immunoglobulins and N-acetylcysteine.

Authors:  Petra Claes; Marjolein Wintzen; Sabine Allard; Patrick Simons; Arlette De Coninck; Patrick Lacor
Journal:  Eur J Intern Med       Date:  2004-07       Impact factor: 4.487

3.  Nevirapine and/or co-trimoxazole induced Stevens Johnson syndrome in HIV infected patient--a case report.

Authors:  Kaksha Patel; Ashwin Panchasara; Bhargav Purohit; C B Tripathi
Journal:  Curr Drug Saf       Date:  2013-02

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

5.  ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis.

Authors:  B Sassolas; C Haddad; M Mockenhaupt; A Dunant; Y Liss; K Bork; U F Haustein; D Vieluf; J C Roujeau; H Le Louet
Journal:  Clin Pharmacol Ther       Date:  2010-04-07       Impact factor: 6.875

6.  Analytical quantification of the inflammatory cell infiltrate and CD95R expression during treatment of drug-induced toxic epidermal necrolysis.

Authors:  Philippe Paquet; Eric Jacob; Pierre Damas; Jean Pirson; Gérald Piérard
Journal:  Arch Dermatol Res       Date:  2005-10-25       Impact factor: 3.017

7.  Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries.

Authors:  Bayaki Saka; Fatou Barro-Traoré; Felix A Atadokpédé; Léon Kobangue; Pascal Antoine Niamba; Hugues Adégbidi; Hubert G Yedomon; Adama Traoré; Vincent P Pitché
Journal:  Int J Dermatol       Date:  2013-01-20       Impact factor: 2.736

8.  A study of the specificity of lymphocytes in nevirapine-induced skin rash.

Authors:  Xin Chen; Tharsika Tharmanathan; Baskar Mannargudi; Hong Gou; Jack P Uetrecht
Journal:  J Pharmacol Exp Ther       Date:  2009-09-04       Impact factor: 4.030

9.  Antiretroviral Therapy in the Real World : Population-Based Pharmacoeconomic Analysis of Administration of Anti-HIV Regimens to 990 Patients.

Authors:  Sergio Sabbatani; Roberto Manfredi; Carlo Biagetti; Francesco Chiodo
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

10.  Nevirapine induced toxic epidermal necrolysis and non-Hodgkin lymphoma in a Human Immunodeficiency Virus positive patient.

Authors:  Leelavathy Budamakuntla; Eswari Loganathan; Shwetha Suryanarayan; Kumar Abhishek; Sacchidanand Sarvajnamurthy
Journal:  Indian Dermatol Online J       Date:  2014-04
View more
  2 in total

1.  Unusual oral findings of the toxic epidermal necrolysis in an HIV-infected patient: a case report.

Authors:  Vinicius da Costa Vieira; Viviane Almeida Sarmento; Patricia Miranda Leite Ribeiro; Eduardo Martins Netto; Carlos Brites; Liliane Lins-Kusterer
Journal:  Braz J Infect Dis       Date:  2019-09-25       Impact factor: 3.257

2.  Orofacial lesions associated with long-term highly active antiretroviral therapy among HIV-seropositive adults in Ibadan, Nigeria.

Authors:  Oluwatoyin Elizabeth Abe; Omotayo Francis Fagbule; Oluwatobi Olubusi Olaniyi; Akinyele Olumuyiwa Adisa; Olalere Omoyosola Gbolahan
Journal:  Pan Afr Med J       Date:  2021-04-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.